Oncology and Hematology

Biomarker Predicts Response to BCMA CAR T-Cell Therapy in Multiple Myeloma
Medical Industry Feature
Biomarker Predicts Response to BCMA CAR T-Cell Therapy in Multiple Myeloma
- Mateo Mejia Saldarriaga, M.D.
  Peer
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry Feature
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
- Jennifer Caudle, DO, FACOFP
  Peer
- Jules Cohen, MD
  Peer
An Exploration of Multiple Myeloma Treatments
Project Oncology®
An Exploration of Multiple Myeloma Treatments
Key Considerations for G-CSF Administration in Patients with FN Risk
Medical Industry Feature
Key Considerations for G-CSF Administration in Patients with FN Risk
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Arielle Heeke, MD
  Peer
advertisement